Longevity Health Holdings, Inc. (NASDAQ:XAGE) Short Interest Up 358.0% in September

Longevity Health Holdings, Inc. (NASDAQ:XAGE) was the recipient of a large growth in short interest during the month of September. As of September 15th, there was short interest totaling 40,300 shares, a growth of 358.0% from the August 31st total of 8,800 shares. Based on an average trading volume of 81,800 shares, the days-to-cover ratio is presently 0.5 days. Based on an average trading volume of 81,800 shares, the days-to-cover ratio is presently 0.5 days.

Hedge Funds Weigh In On Longevity Health

A hedge fund recently bought a new stake in Longevity Health stock. Bank of Montreal Can acquired a new stake in shares of Longevity Health Holdings, Inc. (NASDAQ:XAGE) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,000 shares of the company’s stock, valued at approximately $30,000. Bank of Montreal Can owned about 1.20% of Longevity Health as of its most recent SEC filing. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Longevity Health from a “sell” rating to a “hold” rating in a report on Saturday, August 9th.

Longevity Health Trading Up 10.7%

Shares of NASDAQ:XAGE opened at $0.83 on Friday. The business has a 50-day moving average of $2.12. Longevity Health has a fifty-two week low of $0.57 and a fifty-two week high of $38.10.

Longevity Health (NASDAQ:XAGE) last issued its quarterly earnings results on Thursday, August 14th. The company reported ($1.56) earnings per share for the quarter. The company had revenue of $0.50 million for the quarter.

About Longevity Health

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing.